Although tissue-specific differences may account for some of these discrepancies in miR181ab1 expression and function, the data described here unequivocally demonstrate that miR181ab1 functions as a pro-oncogenic miRNA in lung and pancreatic tumors in which the KRAS oncogene is expressed. Here, KRAS is linked to pancreatic neoplasm.